Synthaverse S.A. Logo

Synthaverse S.A.

BML | WAR

Overview

Corporate Details

ISIN(s):
PLBMDLB00018 (+3 more)
LEI:
259400OWZM67D079S374
Country:
Poland
Address:
LUBLIN UNIWERSYTECKA 10, 20-029 LUBLIN
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Synthaverse S.A. is a pharmaceutical and biotechnology company with a history dating back to 1944. The company develops, manufactures, and sells medicinal products (both prescription and OTC), medical devices, and laboratory reagents. Its portfolio focuses on treatments in the areas of oncology, hematology, and immunology, with products sold in approximately 50 countries. Key brands include Onko BCG, a drug for bladder cancer, and the BCG 10 anti-tuberculosis vaccine, for which the company is the sole supplier in Poland. Synthaverse emphasizes the use of its own proprietary technologies and close cooperation with scientific centers to drive research and innovation.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Synthaverse S.A.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-08 08:48
Regulatory News Service
Zatwierdzenie przez Prezesa URPL zwiększenia wielkości serii Onko BCG 100 - Con…
Polish 1.6 KB
2025-08-27 15:08
Share Issue/Capital Change
Zawarcie umowy objęcia akcji serii W - Content (PL)
Polish 1.9 KB
2025-08-26 19:40
Share Issue/Capital Change
zal01_uchwala_Zarzadu_nr_6_2025.pdf
Polish 407.8 KB
2025-08-26 19:40
Share Issue/Capital Change
Podwyższenie kapitału zakładowego w ramach kapitału docelowego poprzez emisję a…
Polish 2.5 KB
2025-08-25 12:37
Registration Form
zal01_STATUT_tekst_jedn._na_31.07.2025.pdf
Polish 663.4 KB
2025-08-25 12:37
Registration Form
Rejestracja przez sąd zmiany statutu emitenta - Content (PL)
Polish 5.2 KB
2025-08-01 11:16
Declaration of Voting Results & Voting Rights Announcements
zal01_ESPI-wykaz-akcjonariuszy-posiadajacych-co-najmniej-5-glosow-na-NWZA-31.07…
Polish 142.0 KB
2025-08-01 11:16
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Nadzwyczajnym Walnym…
Polish 351 bytes
2025-08-01 11:10
Post-Annual General Meeting Information
zal01_UCHWALY_PODJETE_NWZA_31.07.2025.pdf
Polish 247.2 KB
2025-08-01 11:10
Declaration of Voting Results & Voting Rights Announcements
Treść uchwał podjętych przez Nadzwyczajne Walne Zgromadzenie Emitenta w dniu 31…
Polish 1.1 KB
2025-07-14 17:47
Board/Management Information
Rozszerzenie składu zarządu Spółki Synthaverse S.A. - Content (PL)
Polish 4.9 KB
2025-07-09 17:51
Major Shareholding Notification
zal01_FormularzF.pdf
Polish 89.4 KB
2025-07-09 17:51
Major Shareholding Notification
Znaczne pakiety akcji - zmiana w ogólnej liczbie głosów - Content (PL)
Polish 669 bytes
2025-07-08 17:47
Major Shareholding Notification
zal01_FormularzA_ponizej_5_proc.pdf
Polish 77.8 KB
2025-07-08 17:47
Major Shareholding Notification
zal02_FormularzA_powyzej_5_proc.pdf
Polish 77.8 KB

Automate Your Workflow. Get a real-time feed of all Synthaverse S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Synthaverse S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK